Table 1 Description of baseline, periprocedural and outcome characteristics
n = 82 | |
|---|---|
Age, y (SD) | 77.9 (8.0) |
Female sex, % (n) | 39 (32) |
Median prestroke mRS (IQR) | 0 (0–2) |
Median NIHSS (IQR) | 16 (11–19) |
Median ASPECTS (IQR) | 9 (7–10) |
Cardiovascular risk factors, % (n) | |
Hypertension | 89 (73) |
Diabetes | 32 (26) |
Dyslipidemia | 55 (45) |
Atrial fibrillation, known | 82 (67) |
Atrial fibrillation, newly diagnosed | 18 (15) |
Baseline medication, % (n) | |
Antiplatelet therapy | 24 (20) |
Oral anticoagulation | 37 (30) |
Procedural results | |
IVT, % (n) | 38 (31) |
mTICI ≥ 2b, % (n) | 92 (73) |
Passages, n (IQR) | 1 (1–2) |
Median time SO to ADM (IQR) | 161 (81–209)# |
Median time LSW to ADM (IQR) | 453.5 (290.5–787.75)# |
Median time ADM to GRO (IQR) | 57 (33–96) |
Median time GRO to FLR (IQR) | 57 (36–90) |
Periprocedural complications | |
Dissection, perforation, % (n) | 5 (4) |
ICH, % (n) | 2 (2) |
Vasospasm, % (n) | 1 (1) |
Resuscitation, % (n) | 2 (2) |
Other, % (n) | 2 (2) |
Hospital stay | |
Malignant MCA infarction, % (n) | 4 (3) |
Recurrent stroke, % (n) | 13 (11) |
In-stent thrombosis, % (n) | 4 (3) |
ICH, % (n) | 15 (12) |
Myocardial infarction, % (n) | 0 |
Groin hematoma/aneurysm, % (n) | 2 (2) |
Other complications, % (n) | 28 (23) |
Median duration of stay, d (IQR) | 8 (5–13) |
Outcome | |
In-hospital mortality, % (n) | 21 (17) |
Median discharge mRS (IQR) | 4 (3–5) |
Median discharge NIHSS (IQR) | 10 (5–19) |
Median mRS at 90 days (IQR) | 4 (2–6) |
mRS 0–2 at 90 days, % (n) | 27 (19) |
Mortality at 90 days, % (n) | 39 (28) |